Barclays Plc has hired Jefferson Rives as a managing director covering healthcare services in its healthcare investment banking group, the latest in a slew of banker moves on Wall Street. 

Photo Credit: Bloomberg News

Rives will join from Wells Fargo & Co. and will advise health-care information technology firms, health insurance payers and pharmaceutical supply chain companies, according to a statement. He’ll be based in New York and report to Rick Landgarten, global head of Barclays’s healthcare and real estate groups.

His hire follows Barclays’s appointments in September of Amit Tyagi as a managing director covering tools and diagnostics in its healthcare group and Naeem Merchant, who joined from Greenhill & Co. to cover pharmaceutical-services and technology.

Rives has worked in the industry for 15 years and previously worked at Morgan Stanley and Jefferies Financial Group Inc. He’s advised on more than $175 billion worth of deals and financings including Pantherx Rare Pharmacy’s sale to Centene Corp. and MeMD’s sale to Walmart Inc.

“Jefferson has outstanding knowledge of the healthcare services space, and his extensive transactional experience and deep roster of key relationships will deliver great value for our clients,” Landgarten said in the statement. “We look forward to succeeding together as a team, and further accelerating our HCIT and broader health-care business momentum.”

Barclays has advised on some of the year’s top deals in the sector, including Thermo Fisher Scientific Inc.’s $17.4 billion acquisition of PPD Inc. and insurer Centene Corp.’s $2.2 billion acquisition of Magellan Health Inc.